C-terminal-PEDF reduces IC50 doses and chemoresistant population of CD133 and BCRP1-positve cancer stem like cells

1. Castro-Garcia, P.
2. Gil-Gas, C.
3. Honrubia-Gómez, P.
4. Alvarez-Simón, C.B.
5. Ferré-Fernández, J.-J.
6. Sánchez-Sánchez, F.
7. Sánchez-Sánchez, J.L.
8. Garcia-Bueno, J.M.
9. Sabater, S.
10. Aparicio, G.
11. Antón-Aparicio, L.M.
12. Ramírez-Castillejo, C.